EXELON Capsules, Rivastigmine, EXELON® 1.5 mg hard capsule, Medicine and Disease informationBy viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use. Capsule, hard. EXELON 1.5 mg: Off-white to slightly yellow powder in a capsule with yellow cap and yellow body, with red imprint “EXELON 1.5 mg” on body. EXELON 3 mg: Off-white to slightly yellow powder in a capsule with orange cap and orange body, with red imprint “EXELON 3 mg” on body. EXELON 4.5 mg: Off-white to slightly yellow powder in a capsule with red cap and red body, with white imprint “EXELON 4.5 mg” on body. EXELON 6 mg: Off-white to slightly yellow powder in a capsule with red cap and orange body, with red imprint “EXELON 6 mg” on body. Administration: Treatment should be initiated and supervised by a physician experienced in the diagnosis and treatment of Alzheimer's dementia or dementia associated with Parkinson's disease. Diagnosis should be made according to current guidelines. Therapy with rivastigmine should only be started if a caregiver is available who will regularly monitor drug intake by the patient. Rivastigmine should be administered twice a day, with morning and evening meals. The capsules should be swallowed whole. The prescribed amount of solution should be withdrawn from the container using the oral dosing syringe supplied. Rivastigmine oral solution may be swallowed directly from the syringe. Rivastigmine oral solution and rivastigmine capsules may be interchanged at equal doses. Initial dose: 1.5 mg twice a day. Dose titration: The starting dose is 1.5 mg twice a day. If this dose is well tolerated after a minimum of two weeks of treatment, the dose may be increased to 3 mg twice a day. Subsequent increases to 4.
